Menu
From molecule to real-world impact
From molecule to real-world impact
Pulsus Pharma is a senior-led consultancy operating as an integrated translational platform across the pharmaceutical lifecycle. Founded by physician Mauricio Silva de Lima, it brings together experienced partners with global expertise to support high-stakes decisions from early-stage science to real-world implementation.
Combining academic rigor with senior executive experience in the pharmaceutical industry, Pulsus delivers tailored, high-impact solutions spanning evidence generation, translational strategy, product launch, and real-world implementation.
Early & Strategic Customer Engagement Models
Medical Launch Readiness Models
Strategic Evidence Generation
Optimize performance of Cross-Functional Teams
Integrated Brand Planning (commercial, medical, access)
Repositioning or Re-launching Key Products, Identifying Promising Assets (BD)
Distinguished Service Professor at Carnegie Mellon University; Stuart Evans, Distinguished Professor, CMU & Director, CMU-Emirates iLab
Pharmaceutical Executive, Board Member and retired Chief Medical Officer at Eli Lilly
Head of Roche Pharma Europe & International
Head of Pipeline and Cell Therapy Global Medical Affairs Takeda Oncology
We welcome conversations on how to translate scientific insights into strategic and real-world impact
Mauricio Silva de Lima, M.D., Ph.D.
Founder & Director, Translational Strategy
📧 Email: msdlima@pulsuspharma.com
📍Location: based in the United Kingdom, with international reach.
Initial discussions are confidential and without obligation.
